Prognia
Drug Database
🇪🇺EU · EMAApplication withdrawnATC: Not yet assigned

Hyalograft C autograft

Marketing Authorisation Holder: Anika Therapeutics S.r.l.

Indication

Repairing defects in the cartilage of the femoral condyles and trochlea (the end of the thigh bone that forms part of the knee) caused by sudden or repetitive trauma.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Hyalograft C autograft — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.